Finally... Some Good News
This "World's Most Admired" company's stock is under $2!

Click to Watch the FREE Presentation
>>>
pixel
Hafrun Fridriksdottir net worth and biography

Hafrun Fridriksdottir Biography and Net Worth

Hafrun Fridriksdottir became Executive Vice President, President of Global Generics R&D in February 2017, after serving as Senior Vice President and President of Global Generics R&D from 2016. Prior to joining Teva, from 2015 to 2016, Ms. Fridriksdottir served as Senior Vice President and President of Global Generics R&D in Allergan plc. From 2002 to 2015, she held positions of increasing responsibility within the Actavis Group, including Senior Vice President, R&D. From 1997 to 2002, Ms. Fridriksdottir served as Divisional Manager of Development at Omega Pharma, until its merger with Actavis. Ms. Fridriksdottir received an MS degree in pharmacy and a Ph.D. in physical pharmacy from the University of Iceland.

What is Hafrun Fridriksdottir's net worth?

The estimated net worth of Hafrun Fridriksdottir is at least $10,957.30 as of May 17th, 2022. Dr. Fridriksdottir owns 1,387 shares of Teva Pharmaceutical Industries stock worth more than $10,957 as of September 25th. This net worth evaluation does not reflect any other assets that Dr. Fridriksdottir may own. Learn More about Hafrun Fridriksdottir's net worth.

What is Hafrun Fridriksdottir's salary?

As the VP of Teva Pharmaceutical Industries Limited, Dr. Fridriksdottir earned a total compensation package of $4,290,333.00 in 2020. Dr. Fridriksdottir earned a salary of $720,000.00, a bonus of $562,500.00, stock awards of $1,999,987.00, non-equity compensation of $828,576.00, and other compensation of $179,270.00. Learn More on Hafrun Fridriksdottir's salary.

How do I contact Hafrun Fridriksdottir?

The corporate mailing address for Dr. Fridriksdottir and other Teva Pharmaceutical Industries executives is 5 BAZEL ST P O B 3190, PETACH TIKVA L3, 49131. Teva Pharmaceutical Industries can also be reached via phone at (723) 914-8213 and via email at [email protected] Learn More on Hafrun Fridriksdottir's contact information.

Has Hafrun Fridriksdottir been buying or selling shares of Teva Pharmaceutical Industries?

Hafrun Fridriksdottir has not been actively trading shares of Teva Pharmaceutical Industries in the last ninety days. Most recently, Hafrun Fridriksdottir sold 130,000 shares of the business's stock in a transaction on Tuesday, May 17th. The shares were sold at an average price of $8.22, for a transaction totalling $1,068,600.00. Following the completion of the sale, the vice president now directly owns 1,387 shares of the company's stock, valued at $11,401.14. Learn More on Hafrun Fridriksdottir's trading history.

Who are Teva Pharmaceutical Industries' active insiders?

Teva Pharmaceutical Industries' insider roster includes Rosemary Crane (Director), Richard Daniell (VP), Sven Dethlefs (EVP), Eric Drape (VP), Hafrun Fridriksdottir (VP), Eliyahu Kalif (CFO), Mark Sabag (Insider), Eli Shani (EVP), and David Stark (VP). Learn More on Teva Pharmaceutical Industries' active insiders.

Are insiders buying or selling shares of Teva Pharmaceutical Industries?

During the last twelve months, insiders at the sold shares 7 times. They sold a total of 265,674 shares worth more than $2,341,876.22. The most recent insider tranaction occured on August, 22nd when CFO Eliyahu Sharon Kalif sold 55,500 shares worth more than $558,885.00. Insiders at Teva Pharmaceutical Industries own 0.8 % of the company. Learn More about insider trades at Teva Pharmaceutical Industries.

Information on this page was last updated on 8/22/2022.

Hafrun Fridriksdottir Insider Trading History at Teva Pharmaceutical Industries

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/17/2022Sell130,000$8.22$1,068,600.001,387View SEC Filing Icon  
8/10/2021Sell50,860$9.95$506,057.00View SEC Filing Icon  
12/2/2019Sell4,310$10.49$45,211.9024,883View SEC Filing Icon  
3/18/2019Sell356$16.63$5,920.2816,841View SEC Filing Icon  
1/2/2019Sell1,643$15.70$25,795.1013,469View SEC Filing Icon  
11/30/2018Sell933$21.76$20,302.089,762View SEC Filing Icon  
See Full Table

Hafrun Fridriksdottir Buying and Selling Activity at Teva Pharmaceutical Industries

This chart shows Hafrun Fridriksdottir's buying and selling at Teva Pharmaceutical Industries by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Teva Pharmaceutical Industries Company Overview

Teva Pharmaceutical Industries logo
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, it focuses on the central nervous system, pain, respiratory, and oncology areas. Its products in the central nervous system include Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. The company's products in the respiratory market comprise ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, and ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease. Its products in the oncology market include Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. Teva Pharmaceutical Industries Limited has a collaboration MedinCell for the development and commercialization of multiple long-acting injectable products, a risperidone suspension for the treatment of patients with schizophrenia. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.
Read More

Today's Range

Now: $7.90
Low: $7.75
High: $8.01

50 Day Range

MA: $9.25
Low: $7.01
High: $11.21

2 Week Range

Now: $7.90
Low: $6.78
High: $11.34

Volume

9,314,700 shs

Average Volume

10,787,244 shs

Market Capitalization

$8.77 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.27
Finally... Some Good News
This "World's Most Admired" company's stock is under $2!

Click to Watch the FREE Presentation
>>>
pixel